As shown in Figure 3A, following 48-h treatment with HE on Hepa-RG cells, the in vitro anti-inflammatory activity of HE was monitored by assessing the protein expression levels of the inflammation-related enzyme COX-2 and examining its modulation by the NF-κB transcription factor p65. Here, PTGS2 is linked to hereditary elliptocytosis.